convulsants, nicotine and cannabinoids

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/33

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:13 AM on 5/4/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

34 Terms

1
New cards

examples of convulsant drugs

  • pentylenetetrazol

  • penicillin

  • bicuculline

  • gabazine

  • strychnine

2
New cards

Draw a timeline to show the key components of an experiment using a convulsant of

your choice to investigate antiepileptic drugs in a rodent model. It should include

administration of an appropriate convulsant, and examples of tests used to measure

behavioural and other outputs

PTZ, penicillin, bicuculine, gabazine etc.

- Behavioural tests e.g. motor activity, cognitive tests.

- EEG recordings.

- Effect of antiepileptic drugs.

3
New cards

usage of pentylenetetrazol

  • induce seizures

  • once used in ECT

4
New cards

mechanism of pentylenetetrazol (PTZ)

  • GABA-A antagonist

  • binds to picrotoxin site on chloride channel, inhibits influx and reduces inhibitory neurotransmission

  • NMDA receptor activation

  • inc Ca2+ and Na+ influx

5
New cards

penicillin mechanism and usage

  • non comp antagonist of GABA-A

  • does not cross the BBB

    • applied directly to the cortical surface or intracerebral injection

    • widely used to test anticonvulsants

6
New cards

uses of bicuculine and gabazine

  • GABA-A antagonists

  • used to block GABA-A activity

  • used to dissect CNS circuits pharmacologically

7
New cards

bicuculine

  • plant derived alkaloid

  • competitive antagonist to GABA-A

8
New cards

gabazine

  • potent selective antagonist of GABA-A

  • blocks fast inhibitory synaptic transmission

  • more effective in vitro then bicuculine

9
New cards

strychnine mechanism

  • competitive antagonist to glycine postsynaptic receptors

  • spinal cord and brainstem

10
New cards

strychnine effect

  • leads to constant muscle contractions

  • jaw lock, back arching, breathing difficulties

11
New cards

nicotine mechanism of action

  • agonist at nAChR in brain, NMJ and autonomic ganglia

  • cell depolarisation

  • trigger release of dopamine in mesolimbic system

    • leading to reward and reinforcement

12
New cards

Which subunits of nAChRs are critical for addiction pathways in the brain?

alpha 4 and beta 2

13
New cards

Peripheral effects of nicotine

  • stimulates autonomic ganglia

  • inc heart rate, bp, epinephrine release

14
New cards

Desensitisation and Addiction with nicotine

  • chronic use leads to receptor desensitisation and upregulation

  • contributes to tolerance, cravings and withdrawal symptoms

15
New cards

Expression pattern of nAChR with nicotine

  • activates and induces receptor desensitisation, chronic administration paraodixcally inc nAChR

  • push and pull

16
New cards

behavioural effects of nicotine

  • inhibits spinal reflex

  • low dose - central arousal, improved reaction time

  • higher dose - sedation

  • excitation of mesolimbic dopaminergic reward system

17
New cards

how does nicotine inhibit spinal reflex

  • stimulation of glycinergic renshaw cells

  • spinal inhibitory interneurons - recurrent inhibition

18
New cards

harmful effects/negatives of nicotine

  • cough

  • cancer

  • coronoary heart disease

  • COPD

  • smell, cost

19
New cards

Ingestion of cannabis provides what effects?

  • euphoria

  • calmness

  • relaxation

  • reduced pain

  • inc laughter

  • hunger

  • dizziness

20
New cards

Negatives to cannabis

− ↓ problem-solving, short-term memory, psychomotor performance.

− High doses can lead to personality changes, hallucinations.

− High THC content linked to schizophrenia.

− Minor evidence of tolerance, physical dependence (heavy users?).

21
New cards

active ingredients of cannabis

  • mainly THC

  • CBD

  • cannabinol

22
New cards

which ingredients of cannabis lack psychoactivity

  • cannabinol

  • CBD

23
New cards

effects of cannabis on the cns

  • relaxation

  • sharpened awareness

  • slowing down of time

  • analgesia

  • antiemetic activity

24
New cards

peripheral effects of cannabis

  • tachycardia

  • vasodilation - blood shot eyes

  • reduced intraocular pressure

  • broncodilation

25
New cards

overdose of cannabis

  • mild respiratory depression, confusion, dizziness

  • teratogenic in rodents, not seen in humans

26
New cards

chronic thc usage effects

  • rapid pharmacological tolerance

  • frequent use can cause insomnia, irritability and anxiety upon cessation

  • dependency and potential addiction

27
New cards

exogenous effect of THC

  • THC affects the DA synapse

  • THC binds to CB1

    • release of cAMP

    • dephosphorylation of Ca2+ channel

    • rise of intracellular calcium dec

    • less GABA released

    • less inhibition of DA neuron

    • increased excitability, inc dopamine release

28
New cards

endogenous effects of cannabis

  • rise in calcium postsynaptically through NMDA-R

  • anandamide and 2AG are synthesised from membrane lipids

  • act on CB1 receptors pre synaptically

  • retrograde neurotransmission

29
New cards

anandamide and 2AG synthesis

  • on demand

  • no vesicular release

  • analogue switch

30
New cards

distribution of cb1 receptors

  • found presynaptically

  • High concentrations are found in the basal ganglia, hippocampus, cerebellum, and cerebral cortex.

  • can be upregulated in response to dec endocannabinoid signalling

31
New cards

examples where CB1 receptors are upregulated

  • Chronic stress

  • Cannabinoid withdrawal

  • Parkinson’s disease

  • Schizophrenia

  • Inflammation

32
New cards

endocannabinoid mechanism

  • vesicular release of neurtransmitter

  • depolarisation of postsynaptic membrane

  • calcium influx (POST)

  • enzymatic production of endocannabinoids (POST)

  • endocannabinoids diffuse back to bind to CB1

  • dec activity of calcium channels

  • less calcium influx upon depolarisation

  • less neurotransmitter release

33
New cards

rimonabant

  • selective CB1 inverse agonist

  • acts centrally in the hypothalamus to reduce hunger and peripherally in adipose tissue and liver to inc metabolism

  • used in - obesity, prader willi syndrome

34
New cards

THC and CB agonist possible therapeutic usage

  • reduce motor tics in tourettes

  • produced in basal ganglia, dopamine link